At 52 weeks, semaglutide-treated patients saw a mean improvement of 16.6 points in their scores on the Kansas City Cardiomyopathy Questionnaire (KCCQ), a validated measure of heart failure-related symptoms and physical limitations, compared with an 8.7-point improvement in the placebo group
The safety and efficacy of semaglutide tablets was evaluated in a total of 9 studies in patients on a variety of background therapies
Primary care relevance: Offers a new prescription option for motion sickness prevention with a different mechanism than scopolamine or antihistamines
Ozempic can cause serious side effects, including pancreatitis (inflammation of the pancreas), diabetic retinopathy, and gallbladder or kidney problems
A lower A1C, improved triglycerides, and modest weight loss are not disqualifying findings for any employment context, but it is worth knowing that a full metabolic panel would reflect your semaglutide use indirectly